AGP Executive Report
Last update: an hour agoSemaglutide and tirzepatide Reality Check: A new British Medical Journal analysis of 262 trials finds most obesity drugs, including Wegovy and Mounjaro, don’t meaningfully improve quality of life and bring higher side effects, muscle loss, and dropouts—while only limited cardiovascular benefits show up for injectable semaglutide and tirzepatide. Digital Age Rules: India is weighing a “graded” approach to social media limits for minors after studying Australia’s under-16 age-verification law; some Indian states are already drafting their own restrictions. Denmark Energy Planning: Denmark will designate nine new state energy parks across six municipalities to speed up green electricity build-out like wind and solar. Health Safety in Denmark: Denmark’s Medicines Agency reports a nationwide study linking certain hormonal contraceptives to rare meningioma brain tumors, with the strongest signal for Depo-Provera. EU Innovation Score: The European Innovation Scoreboard says EU innovation performance is up 11.6 points since 2019, with Denmark among the leaders. Semiconductor Supply Chain: GlobalWafers and Micron move toward a 10-year long-term agreement to strengthen US memory-chip materials and manufacturing.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
